Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Changes of orexin A plasma levels in girls with anorexia nervosa during eight weeks of realimentation

J. Bronsky, J. Nedvidkova, H. Krasnicanova, M. Vesela, J. Schmidtova, J. Koutek, R. Kellermayer, M. Chada, Z. Kabelka, M. Hrdlicka, J. Nevoral, R. Prusa

. 2011 ; 44 (6) : 547-52.

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc12028118

OBJECTIVE: Orexin A (OXA) is a hypothalamic neuropeptide involved in regulation of food intake and nutritional status. There are multiple disturbances of neuropeptide signaling described in girls with anorexia nervosa (AN), but OXA levels have not been addressed in this population to date. Therefore, we analyzed OXA levels of AN girls in this study. METHOD: OXA (radioimmunoassay/RIA/method), leptin, insulinlike growth factor-1 (IGF-1), and insulinlike growth factor-1 binding protein-3 (IGFBP-3) levels were measured before and after 8 weeks of realimentation in 36 girls with AN and in 14 healthy controls (control group: CG). RESULTS: Average weight increased significantly in AN during the study (p < .0001), while plasma levels of OXA decreased (before realimentation: 56.2 ± 2.4 pg/ml; after realimentation: 47.5 ± 1.4 pg/ml; p = .0025). OXA levels before realimentation differed from levels in the CG (47.15 ± 2.6 pg/ml, p = .034), but not afterward. We did not find any correlation between OXA and age, height, weight, BMI; or IGF-1, IGFBP-3, and leptin levels. DISCUSSION: OXA levels in untreated AN patients differ significantly from healthy subjects and decrease during realimentation. These findings indicate that OXA may be involved in the nutritional regulation of malnourished children and adolescents.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12028118
003      
CZ-PrNML
005      
20130602200108.0
007      
ta
008      
120817s2011 xxu f 000 0#eng||
009      
AR
024    7_
$a 10.1002/eat.20857 $2 doi
035    __
$a (PubMed)21823139
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Bronský, Jiří, $d 1977- $7 xx0143516 $u Department of Pediatrics, Second Medical Faculty, Charles University and University Hospital Motol, Prague, Czech Republic. bronsky@email.cz
245    10
$a Changes of orexin A plasma levels in girls with anorexia nervosa during eight weeks of realimentation / $c J. Bronsky, J. Nedvidkova, H. Krasnicanova, M. Vesela, J. Schmidtova, J. Koutek, R. Kellermayer, M. Chada, Z. Kabelka, M. Hrdlicka, J. Nevoral, R. Prusa
520    9_
$a OBJECTIVE: Orexin A (OXA) is a hypothalamic neuropeptide involved in regulation of food intake and nutritional status. There are multiple disturbances of neuropeptide signaling described in girls with anorexia nervosa (AN), but OXA levels have not been addressed in this population to date. Therefore, we analyzed OXA levels of AN girls in this study. METHOD: OXA (radioimmunoassay/RIA/method), leptin, insulinlike growth factor-1 (IGF-1), and insulinlike growth factor-1 binding protein-3 (IGFBP-3) levels were measured before and after 8 weeks of realimentation in 36 girls with AN and in 14 healthy controls (control group: CG). RESULTS: Average weight increased significantly in AN during the study (p < .0001), while plasma levels of OXA decreased (before realimentation: 56.2 ± 2.4 pg/ml; after realimentation: 47.5 ± 1.4 pg/ml; p = .0025). OXA levels before realimentation differed from levels in the CG (47.15 ± 2.6 pg/ml, p = .034), but not afterward. We did not find any correlation between OXA and age, height, weight, BMI; or IGF-1, IGFBP-3, and leptin levels. DISCUSSION: OXA levels in untreated AN patients differ significantly from healthy subjects and decrease during realimentation. These findings indicate that OXA may be involved in the nutritional regulation of malnourished children and adolescents.
650    _2
$a mladiství $7 D000293
650    _2
$a mentální anorexie $x krev $x terapie $7 D000856
650    _2
$a tělesná hmotnost $x fyziologie $7 D001835
650    _2
$a přijímání potravy $x fyziologie $7 D004435
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a IGFBP-3 $x krev $7 D018972
650    _2
$a insulinu podobný růstový faktor I $x metabolismus $7 D007334
650    _2
$a intracelulární signální peptidy a proteiny $x krev $7 D047908
650    _2
$a leptin $x krev $7 D020738
650    _2
$a neuropeptidy $x krev $7 D009479
650    _2
$a nutriční stav $7 D009752
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Nedvídková, Jara, $d 1938- $7 jk01082905
700    1_
$a Krásničanová, Hana, $d 1954- $7 nlk20000083887
700    1_
$a Veselá, Marie
700    1_
$a Schmidtová, Jana, $d 1970- $7 pna2007424636
700    1_
$a Koutek, Jiří, $d 1955- $7 jn20000401448
700    1_
$a Kellermayer, Richard
700    1#
$a Chada, Martin. $7 xx0036248
700    1_
$a Kabelka, Zdeněk, $d 1951-2014 $7 xx0053507
700    1_
$a Hrdlička, Michal, $d 1965- $7 jn99240000325
700    1_
$a Nevoral, Jiří, $d 1942- $7 jn19990202013
700    1_
$a Průša, Richard, $d 1962- $7 nlk19990073743
773    0_
$w MED00002314 $t The International journal of eating disorders $x 1098-108X $g Roč. 44, č. 6 (2011), s. 547-52
856    41
$u https://pubmed.ncbi.nlm.nih.gov/21823139 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m
990    __
$a 20120817 $b ABA008
991    __
$a 20130602200453 $b ABA008
999    __
$a ok $b bmc $g 950160 $s 785464
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2011 $b 44 $c 6 $d 547-52 $i 1098-108X $m The International journal of eating disorders $n Int. j. eat. disord.(Print) $x MED00002314
LZP    __
$a Pubmed-20120817/11/04

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...